Abstract:Objectives: Osteoporosis (OP) is a systemic disease caused by imbalance between bone resorption and bone formation, commonly resulting from post-menopausal oestrogen deficiency. Although osteogenic differentiation potential of adipose-derived stem cells (ASCs) has been demonstrated, the effect of OP on osteogenic differentiation of ASCs remains unclear. Here, our work has been designed to compare proliferative capacity and osteogenic differentiation ability of ASCs obtained from osteoporotic mice and normal control mice.Materials and methods: Twenty 14-week-old female C57BL/6 mice were randomly divided into two groups: one, the ovariectomy (OVX) group (n=10), the other being the sham operated (Sham) group (n=10). ASCs and OP-ASCs were obtained from subcutaneous fat of female inguinal sites. Cells were passaged three times prior to subsequent experimentation. The xCELLigence system was used to monitor cell adhesion and proliferation. Mineralized nodules of differentiated ASCs and OP-ASCs were analysed using Alizarin red staining after osteogenic induction. Expressions of osteogenic-specific genes including osteopontin (Opn) and runt-related transcription factor 2 (Runx2) were assessed by real-time PCR and expression of bone-related proteins was detected by Western blotting.Results: Numbers of cells in all groups increased steadily for 6 days; rate of cell proliferation in the Sham group was found to be higher than in the OVX group after 48 hours. Mineralized bone nodular structures were significantly more concentrated in the Sham group than in the OVX group by day 21, and mRNA levels of Runx2 in the OVX group were significantly lower than in the Sham group. Transcript levels of genes coding for Opn showed a similar pattern to those of Runx2. Western blot results indicated that protein expression levels of OPN and RUNX2 in the OVX group were lower than those in the Sham group, at each time point.Conclusions: These results indicated that the proliferative capacity and osteogenic potential of ASCs were significantly impaired in osteoporotic mice compared to normal controls. However, use of autologous transplantation of modified OP-ASCs for treatment of OP, or combination of composite scaffolds and modified OP-ASCs for repair of osteoporotic bone defects, can overcome shortcomings of other methods.

Co-administration of aspirin and allogeneic adipose-derived stromal cells attenuates bone loss in ovariectomized rats through the anti-inflammatory and chemotactic abilities of aspirin

Asperosaponin VI Promotes Bone Marrow Stromal Cell Osteogenic Differentiation Through the PI3K/AKT Signaling Pathway in an Osteoporosis Model

[Effect of aspirin administration for the treatment of osteoporosis in ovariectomized rat model]

Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats

The preventive effect of aspirin on osteoporosis in ovariectomized rat

Pharmacologic Stem Cell Based Intervention As a New Approach to Osteoporosis Treatment in Rodents

Astilbin Prevents Bone Loss in Ovariectomized Mice Through the Inhibition of RANKL‐induced Osteoclastogenesis

Aspirin Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Osteoclastogenesis and Promoting Osteogenesis

Adipose tissue-derived stem cells in the ovariectomy-induced postmenopausal osteoporosis rat model

The Preventive Effect of Asprin on Osteoporosis in Ovariectomized Rat

Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats

S-Allylmercapto-N-Acetylcysteine (ASSNAC) Attenuates Osteoporosis in Ovariectomized (OVX) Mice

Osteogenic Differentiation Potential of Adipose-Derived Stem Cells from Ovariectomized Mice.

Bisphosphonate-related osteonecrosis. Application of adipose-derived stem cells in an experimental murine model

Lower Dosage of Aspirin Promotes Cell Growth and Osteogenic Differentiation in Murine Bone Marrow Stromal Cells.

Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro.

In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model

Local Administration of Aspirin with Β-Tricalcium Phosphate/poly-Lactic-co-glycolic Acid (Β-Tcp/plga) Could Enhance Osteoporotic Bone Regeneration.

Aspirin enhances the osteogenic and anti-inflammatory effects of human mesenchymal stem cells on osteogenic BFP-1 peptide-decorated substrates

Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine